ryanodine; Schistosoma mansoni; calcium; praziquantel
RESEARCH NOTE
Evidence for Functional Ryanodine Receptors in Schistosoma mansoni and their Putative Role in the Control of Calcium Homeostasis
CLM Silva, DL Mendonça-Silva, F Noël+
Departamento de Farmacologia Básica e Clínica, ICB, Universidade Federal do Rio de Janeiro, Cidade Universitária, 21941-590 Rio de Janeiro, RJ, Brasil
Key words: ryanodine - Schistosoma mansoni - calcium - praziquantel
RESEARCH NOTE
RESEARCH NOTE
The main musculature present in adult male Schistosoma mansoni is mainly of the smooth muscle type (MH Silk & IM Spence 1969 S Afr J Med Sci 34: 11-20). As we have previously demonstrated, the contraction of S. mansoni presents a tonic component, dependent on extraworm calcium, and a phasic one, dependent on intracellular/intraworm calcium (S da Silva & F Noël 1995 Parasitol Res 81: 543-548). Since intracellular calcium channels sensitive to the alkaloid ryanodine and therefore known as ryanodine receptors (RyR) (R Coronado et al. 1994 Am J Physiol 266: C1485-C1504) have been demonstrated in a variety of mammalian as well as non-mammalian (chicken, frog) and non-vertebrate cells (Caenorhabditis elegans, lobster and drosophila) (G Meissner 1994 Annu Rev Physiol 56: 485-508), the main objective of this work was to investigate the presence of RyR in S. mansoni, as well as their subcellular distribution profile, pharmacological modulation and their putative involvement in S. mansoni contractility.
About 2,000 worms were homogenized in a Dounce homogenizer at 4oC in 0.25 M sucrose solution (5 mM Tris-HCl pH 7.4) using three sequences of ten passes of the pestle. The homogenate was centrifuged to obtain four pellets (P1, P2, P3, P4) sedimenting respectively at 300 gav (5 min); 1000 gav (10 min); 8000 gav (10 min) and 100,000 gav (1 hr) (VMN Cunha et al. 1988 FEBS Lett 241: 65-68).
In the binding assays, 100-150 mg of proteins of subcellular fractions were incubated for 2 hr at 37oCin a medium (0.5 ml) containing 1.5 M KCl, 10 mM Na2ATP, 0.8 mM CaCl2 (107 mM free Ca2+), HEPES 10 mM, NaOH pH 7.4 and 0.3 nM [3H]ryanodine (NEN, 84 Ci/mmol) in the presence or absence of 0.2-10 nM unlabelled ryanodine. Incubations were terminated by dilution of the samples with 5 ml of ice-cold buffer (150 mM KCl, 10 mM Tris, pH 7.4) followed by rapid filtration on glass fibre filters under vacuum (Whatman GF/C) in order to separate bound and free radioligand. The non-specific binding was determined in the presence 10 mM unlabelled ryanodine. Data from saturation experiments were treated by a computerised non-linear regression analysis (EBDA-LIGAND; Elsevier-Biosoft, Cambridge, UK).
For the in vitro studies, the worms were carefully recovered from mice portal veins, washed and placed in a glass dish containing 3 ml Tyrode's solution maintained at 37oC. After 10 min for equilibration, 100 mM ryanodine or vehicle were added (time zero) and the grading of worm shortening was performed based on the worm length (da Silva & Noël loc. cit.).
The [3H]ryanodine specific binding sites were mainly recovered in the heterogeneous (P1) and microsomal (P4) fractions of S. mansoni (Table I). Analysis of the data from four saturation experiments revealed an equilibrium dissociation constant (Kd) in the low nanomolar range (6.9 ± 0.6 nM), a maximal number of receptors (Bmax) of 78 ± 18 fmol/mg protein. We tested the influence of Ca2+ and Mg2+ on the binding of [3H]ryanodine to the P1 fraction. As the free concentration of Ca2+ was increased from 0.3 to 107 mM there was a corresponding increase in the [3H]ryanodine specific binding (Table II). On the other hand 5 mM free Mg2+, in the absence of ATP, inhibited about 50% the [3H]ryanodine specific binding (Table II). Praziquantel, even at a concentration 10-fold higher than its therapeutic plasma concentration, had no effect on [3H]ryanodine binding (Table II). Finally ryanodine was able to contract the whole S. mansoni in a time-dependent manner (Fig.).
[3H]ryanodine specific binding sites were mainly recovered in the heterogeneous (P1) and microsomal (P4) fractions of S. mansoni. These binding sites have a similar pattern of subcellular distribution as the (Ca2+-Mg2+)ATPase sensitive to thapsigargin, that corresponds to a SERCA ATPase (VMN Cunha et al. 1996, Comp Biochem Physiol 114B: 199-205). The saturation experiment at equilibrium revealed the labelling of only one homogeneous population of receptors in the range of concentrations used, and a dissociation constant (Kd) in the nanomolar range, as observed in higher animals (Coronado loc. cit.) or even in the nematode C. elegans (YK Kim et al. 1992 Biophys J 63: 1379-1384). [3H]ryanodine binding correlates with the functional state of the ionic channel (Coronado loc. cit.) so that conditions increasing the open channel probability usually favour the [3H]ryanodine binding whereas conditions that close the channel decrease this binding, as for Ca2+ and Mg2+ respectively. With respect to the ryanodine receptors present in S. mansoni they possess some characteristics qualitatively very similar to those present in higher animals regarding the affinity for ryanodine and the modulatory effect of ions (Ca2+ and Mg2+). Recently, CA Redman et al. (1996 Parasitol Today 12: 14-20) suggested that the mechanism of action of praziquantel could be related to mobilisation of intracellular Ca2+ stores sensitive to IP3 or Ca2+. Here we observed that praziquantel was not able to alter the [3H]ryanodine binding to the subcellular P1 fraction. Other possibilities have just been discharged such as inhibition of (Ca2+- Mg2+) ATPase and (Na+/ K+)ATPase (VMN Cunha & F Noël 1997 Life Sci 60: PL289-294), thus the exact mechanism of action of praziquantel-induced contraction still remains to be elucidated. Finally, a high concentration of ryanodine (100 mM) was able to induce contractions of the whole adult worms, indicating that these receptors may have a role in the control of calcium homeostasis within the worm musculature.
to Dr Lygia dos R Corrêa, Instituto Oswaldo Cruz, who kindly provided the infected mice; to Eliana Freitas and José Ferreira Oliveira for their skilful technical assistance.
This work was supported by CNPq, Faperj, Finep and Pronex no 41.96.0888.00.
+Corresponding author. Fax +55-21-280.4694. E-mail: fnoel@pharma.ufrj.br
Received 4 May 1998
Accepted 31 August 1998
Publication Dates
-
Publication in this collection
14 July 2000 -
Date of issue
1998
History
-
Accepted
31 Aug 1998 -
Received
04 May 1998